SCPH logo

ScPharmaceuticals (SCPH) Cash From Investing

Annual CFI

$19.96 M
+$65.82 M+143.54%

December 31, 2023

Summary

Performance

1-Year Change

+143.54%

3-Year Change

+159.67%

5-Year Change

-

15-Year Change

+10391.24%

SCPH Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.6%
SCPH annual cash flow from investing activities is higher than 81.6% of companies in Healthcare sector

High & Low

All-time High

$32.13 M
SCPH annual cash flow from investing activities is currently -37.86% below its historical high of $32.13 million

3-Year Low

-$45.86 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
SCPH previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 13, 2025
SCPH next annual earnings announcement is scheduled for Mar 13, 2025

OtherSCPHcash flowmetrics:

Annual CFF

$14.85 M
SCPH annual cash flow from financing activities is $14.85 million

Annual CFO

-$59.24 M
SCPH annual cash flow from operations is -$59.24 million

Annual FCF

-$59.28 M
SCPH annual free cash flow is -$59.28 million

Annual CAPEX

$40.00 K
SCPH annual capital expenditures is $40.00 thousand

Quarterly CFI

-$9000.00
-$10.00 K-1000.00%

September 30, 2024

Summary

Performance

3-Month Change

-1000%

1-Year Change

-100.03%

3-Year Change

+99.98%

5-Year Change

+99.98%

SCPH Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

52.24%
SCPH quarterly cash flow from investing activities is higher than 52.24% of companies in Healthcare sector

High & Low

All-time High

$36.70 M
SCPH quarterly cash flow from investing activities is currently -100.02% below its historical high of $36.70 million

3-Year Low

-$42.99 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SCPH previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SCPH next earnings announcement is scheduled for Mar 13, 2025

OtherSCPHcash flowmetrics:

Quarterly CFF

$70.41 M
SCPH quarterly cash flow from financing activities is $70.41 million

Quarterly CFO

-$17.42 M
SCPH quarterly cash flow from operations is -$17.42 million

Quarterly FCF

-$17.43 M
SCPH quarterly free cash flow is -$17.43 million

Quarterly CAPEX

$9000.00
SCPH quarterly capital expenditures is $9000.00

TTM CFI

$55.77 M
+$22.92 M+69.74%

September 30, 2024

Summary

Performance

3-Month Change

+69.74%

1-Year Change

+179.36%

3-Year Change

+221.62%

5-Year Change

+221.62%

SCPH TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

90.39%
SCPH TTM cash flow from investing activities is higher than 90.39% of companies in Healthcare sector

High & Low

All-time High

$64.33 M
SCPH TTM cash flow from investing activities is currently -13.30% below its historical high of $64.33 million

3-Year Low

-$49.49 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
SCPH previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 13, 2025
SCPH next earnings announcement is scheduled for Mar 13, 2025

OtherSCPHcash flowmetrics:

TTM CFF

$71.18 M
SCPH TTM cash flow from financing activities is $71.18 million

TTM CFO

-$70.51 M
SCPH TTM cash flow from operations is -$70.51 million

TTM FCF

-$70.56 M
SCPH TTM free cash flow is -$70.56 million

TTM CAPEX

$46.00 K
SCPH TTM capital expenditures is $46.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

SCPH Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+143.5%-100.0%+179.4%
3 y3 years+159.7%+100.0%+221.6%
5 y5 years-+100.0%+221.6%

SCPH Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-37.9%+143.5%-100.0%+100.0%at high+212.7%
5 y5-year-37.9%+143.5%-100.0%+100.0%-13.3%+179.5%
alltimeall time-37.9%+143.5%-100.0%+100.0%-13.3%+179.5%

ScPharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$9000.00(-1000.0%)
$55.77 M(+69.7%)
Jun 2024
-
$1000.00(-100.0%)
$32.86 M(-22.3%)
Mar 2024
-
$29.32 M(+10.8%)
$42.28 M(+111.8%)
Dec 2023
$19.96 M(-143.5%)
$26.46 M(-215.4%)
$19.96 M(-140.3%)
Sep 2023
-
-$22.93 M(-343.2%)
-$49.49 M(+213.6%)
Jun 2023
-
$9.43 M(+34.7%)
-$15.78 M(-39.5%)
Mar 2023
-
$7.00 M(-116.3%)
-$26.07 M(-43.2%)
Dec 2022
-$45.86 M(-242.7%)
-$42.99 M(-498.7%)
-$45.86 M(-2906.5%)
Sep 2022
-
$10.78 M(-1352.5%)
$1.63 M(+340.4%)
Jun 2022
-
-$861.00 K(-93.3%)
$371.00 K(-94.4%)
Mar 2022
-
-$12.79 M(-384.2%)
$6.63 M(-79.3%)
Dec 2021
$32.13 M(-196.0%)
$4.50 M(-52.7%)
$32.13 M(-50.1%)
Sep 2021
-
$9.52 M(+76.2%)
$64.33 M(+156.1%)
Jun 2021
-
$5.40 M(-57.5%)
$25.12 M(-221.0%)
Mar 2021
-
$12.71 M(-65.4%)
-$20.75 M(-38.0%)
DateAnnualQuarterlyTTM
Dec 2020
-$33.46 M(<-9900.0%)
$36.70 M(-223.6%)
-$33.46 M(-52.3%)
Sep 2020
-
-$29.69 M(-26.6%)
-$70.16 M(+73.4%)
Jun 2020
-
-$40.47 M(<-9900.0%)
-$40.47 M(<-9900.0%)
Mar 2020
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2019
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 2019
-
$0.00(0.0%)
$41.00 K(0.0%)
Jun 2019
-
$0.00(-100.0%)
$41.00 K(>+9900.0%)
Dec 2018
-
$41.00 K(>+9900.0%)
$0.00(-100.0%)
Sep 2018
-
$0.00(-100.0%)
-$45.00 K(-79.8%)
Jun 2018
-
-$41.00 K(+925.0%)
-$223.00 K(+14.9%)
Dec 2017
-$194.00 K(+2055.6%)
-$4000.00(-97.8%)
-$194.00 K(+2.1%)
Sep 2017
-
-$178.00 K(+1383.3%)
-$190.00 K(+1483.3%)
Jun 2017
-
-$12.00 K
-$12.00 K
Dec 2016
-$9000.00(-47.1%)
-
-
Dec 2015
-$17.00 K
-
-

FAQ

  • What is scPharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for scPharmaceuticals?
  • What is scPharmaceuticals annual CFI year-on-year change?
  • What is scPharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for scPharmaceuticals?
  • What is scPharmaceuticals quarterly CFI year-on-year change?
  • What is scPharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for scPharmaceuticals?
  • What is scPharmaceuticals TTM CFI year-on-year change?

What is scPharmaceuticals annual cash flow from investing activities?

The current annual CFI of SCPH is $19.96 M

What is the all time high annual CFI for scPharmaceuticals?

scPharmaceuticals all-time high annual cash flow from investing activities is $32.13 M

What is scPharmaceuticals annual CFI year-on-year change?

Over the past year, SCPH annual cash flow from investing activities has changed by +$65.82 M (+143.54%)

What is scPharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of SCPH is -$9000.00

What is the all time high quarterly CFI for scPharmaceuticals?

scPharmaceuticals all-time high quarterly cash flow from investing activities is $36.70 M

What is scPharmaceuticals quarterly CFI year-on-year change?

Over the past year, SCPH quarterly cash flow from investing activities has changed by -$26.47 M (-100.03%)

What is scPharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of SCPH is $55.77 M

What is the all time high TTM CFI for scPharmaceuticals?

scPharmaceuticals all-time high TTM cash flow from investing activities is $64.33 M

What is scPharmaceuticals TTM CFI year-on-year change?

Over the past year, SCPH TTM cash flow from investing activities has changed by +$35.81 M (+179.36%)